Novo Nordisk has partnered with OpenAI to accelerate drug discovery and development using artificial intelligence, as pharmaceutical companies increasingly turn to AI to improve efficiency and outcomes. The collaboration will focus on analyzing complex biological datasets, identifying potential treatments, and shortening the timeline from early research to patient use. Shares of Novo Nordisk rose about 2.8% following the announcement.

The partnership aims to apply AI to some of the most resource-intensive stages of drug development. By leveraging advanced models, Novo Nordisk expects to uncover patterns in large datasets that would be difficult to detect using traditional methods. This could help researchers identify promising drug candidates earlier and test hypotheses more quickly. The company said the approach could ultimately lead to faster development of treatments, particularly for conditions such as obesity and diabetes, where demand remains high.

For OpenAI, the deal represents a further expansion into the life sciences sector, where AI is increasingly being used to support research, clinical trials, and operational workflows. CEO Sam Altman said the technology has the potential to transform industries by enabling new discoveries and improving health outcomes.

AI’s Growing Role in Pharma

The partnership reflects a broader industry trend. Drugmakers are exploring how AI can streamline processes that traditionally take years and cost billions of dollars. While fully AI-driven drug discovery remains an emerging field, companies are already seeing benefits in areas such as clinical trial design, patient recruitment, and data analysis.

Momentum is building across the sector. Eli Lilly recently signed a $2.75 billion deal with Insilico Medicine to commercialize AI-developed therapies globally, underscoring how major pharmaceutical players are investing heavily in AI-driven pipelines. In parallel, AstraZeneca has entered a $555 million milestone-based partnership with Algen Biotechnologies to combine AI with CRISPR gene-editing for immunology drug discovery. Together, these deals illustrate how AI is moving from experimental use into core R&D and commercialization strategies.

Competing in a High-Stakes Market

Novo Nordisk’s investment in AI comes as it faces intense competition from Eli Lilly in the fast-growing weight loss and diabetes treatment market. The company has been working to strengthen its pipeline with new therapies, including next-generation drugs and alternative formulations.

The partnership also builds on Novo Nordisk’s existing AI initiatives. The company has previously collaborated with Nvidia to leverage high-performance computing infrastructure for drug discovery, including the use of the Gefion supercomputer to develop customized AI models.

By combining its pharmaceutical expertise with OpenAI’s technology, Novo Nordisk is aiming to gain an edge in both innovation speed and treatment development. As AI adoption accelerates across the healthcare sector, such partnerships are likely to become a key differentiator in the race to bring new therapies to market.

X is set to launch its standalone messaging app, XChat, on Apple’s App Store on April 17, marking a major step in Elon Musk’s effort to transform the platform into an all-in-one “super app.” The release follows months of testing and positions messaging as a central component of X’s broader strategy to compete with multifunction platforms like WeChat.

XChat began internal testing in May 2025 and entered public beta on iOS in March 2026. The app builds on X’s existing user base of more than 500 million monthly active users, giving it a potential distribution advantage as it rolls out more advanced communication features. An Android release timeline has not yet been announced.

The messaging app includes a range of privacy and communication tools designed to compete with established platforms. These include end-to-end encryption, voice and video calling, disappearing messages, screenshot blocking, and message recall. XChat is also built using the Rust programming language, which is known for performance and security. Notably, users will be able to sign up without providing a phone number, differentiating it from many competing messaging services.

Building the Super App Layer

XChat is intended to serve as the foundational communication layer for Musk’s broader vision of a super app that integrates messaging, payments, and digital services into a single platform. Musk has repeatedly pointed to WeChat as a model, where users can manage everything from messaging to financial transactions within one ecosystem.

The introduction of a dedicated messaging app suggests X is moving toward a modular approach, where separate but interconnected products form a larger platform. Messaging is typically a core feature in super apps, acting as the gateway for user engagement and service integration.

Competing in a Crowded Market

The launch places X in direct competition with established messaging platforms, including those already offering encryption and multimedia communication. However, X’s differentiation may come from its integration with a broader ecosystem, including social media, content distribution, and potentially financial services.

The ability to onboard users without phone numbers could also appeal to privacy-conscious users, though it may raise regulatory and security questions in some regions.

As Musk continues to reshape X, XChat represents a critical test of whether the company can evolve beyond its origins as a social network into a more comprehensive digital platform. The success of the app may determine how quickly X can expand into additional services and realize its ambitions of becoming a global super app.

Alibaba’s open-source AI video model, HappyHorse-1.0, has surged to the top of global performance rankings, outperforming leading proprietary systems and shaking up the rapidly evolving video generation market. The model now leads the Artificial Analysis Video Arena leaderboard in multiple categories, surpassing ByteDance’s Seedance 2.0 by a significant margin in blind user evaluations.

HappyHorse-1.0 achieved between 1333 and 1357 Elo points in text-to-video generation, beating its closest competitor by nearly 60 points. It also set a new record in image-to-video tasks with scores exceeding 1390 Elo, while ranking second in more complex audio-inclusive benchmarks. The results are notable not only for performance, but because the model is fully open source with commercial licensing, making its capabilities broadly accessible.

The system uses a 15-billion-parameter Transformer architecture designed to generate synchronized audio and video in a single pass. It supports features such as native lip-sync across multiple languages, including Mandarin, English, and Japanese, and can produce 1080p video in under a minute using a single NVIDIA H100 GPU. The full model weights, along with distilled versions and supporting tools, have been released publicly, allowing developers to run the system locally.

HappyHorse-1.0 was developed by an independent research team with roots in Alibaba Group’s former Taotian research unit and led by Zhang Di, previously a senior executive at Kuaishou. The team emphasized a focus on real-world user preference in evaluation, rather than traditional benchmark optimization.

Open Source Gains Ground

The model’s success highlights a broader shift in the AI industry, where open-source systems are increasingly competitive with proprietary offerings. Historically, leading performance in areas like video generation has been dominated by closed models developed by large technology companies. HappyHorse-1.0 suggests that smaller, independent teams can now rival or exceed those capabilities.

This dynamic mirrors trends seen in other areas of AI, including language models and image generation, where open ecosystems have accelerated innovation and lowered barriers to entry. By releasing full model weights and tools, the developers are enabling rapid experimentation and customization across industries.

Implications for the AI Video Market

The emergence of a high-performing open-source video model could intensify competition among AI providers, particularly in creative and media applications. Lower-cost access to advanced video generation may benefit startups and developers, while putting pressure on proprietary platforms to differentiate through features, integration, or performance.

At the same time, the availability of powerful video generation tools raises questions around misuse, content authenticity, and regulation. As capabilities improve, ensuring responsible deployment will remain a key challenge for both developers and policymakers.

HappyHorse-1.0’s rapid rise signals that the balance of power in AI video may be shifting, with open-source innovation playing an increasingly central role in shaping the next phase of the market.